Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator
- 20 February 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 341 (8843) , 504-505
- https://doi.org/10.1016/0140-6736(93)90270-q
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.Heart, 1992
- Factors responsible for the differential procoagulant effects of diverse plasminogen activators in plasmaFibrinolysis, 1991
- Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.Circulation, 1991
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990